8D.05

Authors :: Susan B. Gurley
Khalid M. Elased
Marlies Antlanger
Nadja Grobe
Ralf A. Linker
Christopher C. Kaltenecker
Arndt Manzel
Marcus D. Säemann
Johannes J. Kovarik
Johannes Stegbauer
Marko Poglitsch
Oliver Domenig
Source :: Journal of Hypertension. 33:e114-e115
Publication Year :: 2015
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2015.
Abstract: Objective:Cardiovascular and renal pathology is frequently associated with a hyperactivated Renin-Angiotensin-System (RAS) and increased levels of its vasoconstrictive metabolite Angiotensin II. RAS blockade is a widely used therapeutic approach to treat hypertension and prevent hypertonic nephropat

Tools